Wednesday, June 16, 2021 1:40:01 PM
Successful Clinical Trials should have strong support with the FDA and allowing the expediting of a Re-purposed Drug with a strong safety record.
An relatively inexpensive Pill instead of infusions.?.
The Big Pharma controlled FDA/EMA just changed things for an Alzheimer's drug why not approve COVID/ALI Drug on good Interim data trends with their CT too.?.
The Buc Clinical Trial is using a 28 day following of patients*, so there are a lot of people that have completed their treatments. Is 400 a good point to do an Interim?
The FDA / EMA SHOULD be looking forward with allowing support for treatments, as working with India will be, IMO...GLTA...
* I hope some are followed further as MF implied with mentioning long Haulers.
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM